IKT - Inhibikase Therapeutics Inc Earnings

Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

Peers: GOSS INSM TENX LQDA MNKD KROS UTHR VCRE PLRX MRK

| Held by: VTI IWM VXF IWN VTWO IWC SBIO VTWV AVSC RSSL

Scroll to Statements

Index	RUT
Market Cap	233.02M
Enterprise Value	74.00M
Income	-60.64M
Sales	0.00M
Book/sh	1.16
Cash/sh	1.14
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	35
IPO	Dec 23, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.44
P/C	1.47
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	15.82
Current Ratio	15.82
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.44
EPS next Y	-0.46
EPS next Q	-0.11
EPS this Y	11.33%
EPS next Y	-5.72%
EPS next 5Y	6.39%
EPS past 3/5Y	51.48% 22.00%
Sales past 3/5Y	- -
EPS Y/Y TTM	59.89%
Sales Y/Y TTM	-100.00%
EPS Q/Q	-1.81%
Sales Q/Q	-
Earnings	Aug 11 AMC
EPS/Sales Surpr.	-2.33% -

Insider Own	22.35%
Insider Trans	0.00%
Inst Own	73.32%
Inst Trans	13.03%
ROA	-48.04%
ROE	-51.96%
ROIC	-39.55%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-5.38%
SMA50	-20.18%
SMA200	-13.81%
Trades

Shs Outstand	132.03M
Shs Float	108.35M
Short Float	18.11%
Short Ratio	34.34
Short Interest	19.63M
52W High	2.61 -36.02%
52W Low	1.33 25.56%
Volatility	6.46% 6.55%
ATR (14)	0.11
RSI (14)	39.10
Beta	0.91
Rel Volume	0.00
Avg Volume	571.50K
Volume	0

Perf Week	2.45%
Perf Month	-18.73%
Perf Quarter	-23.39%
Perf Half Y	-11.64%
Perf YTD	-18.54%
Perf Year	16.78%
Perf 3Y	100.64%
Perf 5Y	-86.01%
Perf 10Y	-
Recom	1.20
Target Price	5.55
Prev Close	1.67
Price	1.67
Change %	0.00%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)